Likewise, Ostapchenko et al. (2015) demonstrated that TRPM2 ablation in AD models decreases microglial activation, improves the expression of synaptic markers and reduces the deficits in memory observed in aging animals (Ostapchenko et al., 2015). The gene discussed is TRPM2; the disease is Alzheimer disease.